Literature DB >> 30074182

MiR-21 Suppresses Anoikis through Targeting PDCD4 and PTEN in Human Esophageal Adenocarcinoma.

Meng-Ya Zhao1, La-Mei Wang2, Jing Liu4, Xing Huang4, Jing Liu4, Ya-Fei Zhang5.   

Abstract

Anoikis is a form of apoptosis induced upon cell detachment from extracellular matrix. It has been determined that acquisition of resistance to anoikis is a critical step for tumor cell metastasis. MiR-21, the most prominent oncomiR, plays an important role in tumor progression. In this study, we revealed that up-regulation of miR-21 in human esophageal adenocarcinoma (EA) is associated with lymph node metastasis and poor survival rate. Because of the established anti-apoptosis effect of miR-21, it is tempting to speculate that miR-21 might contribute to tumor metastasis by regulating anoikis. qRT-PCR analysis demonstrated that miR-21 expression in OE33/AR cells (subpopulation of human EA OE33 cells that acquired resistance to anoikis) was significantly increased. Also, transfection of miR-21 mimics provided OE33 cells resisting to anoikis. By luciferase assays, we verified that PDCD4 and PTEN were the functional targets of miR-21. In mouse model, via tail vein injection experiment, we showed that the metastasis formation of OE33 cells in vivo could be mediated by changing the miR-21 expression pattern. Taken together, our findings suggested that miR-21 was involved in the regulation of anoikis in human EA cells. Targeting miR-21 may provide a novel strategy to prevent metastasis.

Entities:  

Keywords:  PDCD4; PTEN; anoikis resistance; esophageal adenocarcinoma; miR-21

Mesh:

Substances:

Year:  2018        PMID: 30074182     DOI: 10.1007/s11596-018-1872-7

Source DB:  PubMed          Journal:  Curr Med Sci        ISSN: 2523-899X


  32 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Underlying Mechanisms for Distant Metastasis - Molecular Biology.

Authors:  Eva Pachmayr; Christoph Treese; Ulrike Stein
Journal:  Visc Med       Date:  2017-02-09

Review 3.  Targeting strategies on miRNA-21 and PDCD4 for glioblastoma.

Authors:  Gang Wang; Jun Jie Wang; Hong Ming Tang; Shing Shun Tony To
Journal:  Arch Biochem Biophys       Date:  2015-07-02       Impact factor: 4.013

Review 4.  Anoikis molecular pathways and its role in cancer progression.

Authors:  Paolo Paoli; Elisa Giannoni; Paola Chiarugi
Journal:  Biochim Biophys Acta       Date:  2013-07-02

5.  Targeting miR-21 for the therapy of pancreatic cancer.

Authors:  Flavie Sicard; Marion Gayral; Hubert Lulka; Louis Buscail; Pierre Cordelier
Journal:  Mol Ther       Date:  2013-03-12       Impact factor: 11.454

6.  Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment.

Authors:  Zachary T Schafer; Alexandra R Grassian; Loling Song; Zhenyang Jiang; Zachary Gerhart-Hines; Hanna Y Irie; Sizhen Gao; Pere Puigserver; Joan S Brugge
Journal:  Nature       Date:  2009-08-19       Impact factor: 49.962

Review 7.  The critical roles of miR-21 in anti-cancer effects of curcumin.

Authors:  Jiezhong Chen; Tiefeng Xu; Chen Chen
Journal:  Ann Transl Med       Date:  2015-12

Review 8.  Integration of autophagy and anoikis resistance in solid tumors.

Authors:  Jie Yang; Zhichao Zheng; Xiaojie Yan; Xia Li; Zhe Liu; Zhenyi Ma
Journal:  Anat Rec (Hoboken)       Date:  2013-08-20       Impact factor: 2.064

Review 9.  AKT kinase pathway: a leading target in cancer research.

Authors:  Ambuj Kumar; Vidya Rajendran; Rao Sethumadhavan; Rituraj Purohit
Journal:  ScientificWorldJournal       Date:  2013-11-13

10.  Expression analysis of miRNA and target mRNAs in esophageal cancer.

Authors:  X R Meng; P Lu; J Z Mei; G J Liu; Q X Fan
Journal:  Braz J Med Biol Res       Date:  2014-08-01       Impact factor: 2.590

View more
  7 in total

Review 1.  The potential roles and mechanisms of non-coding RNAs in cancer anoikis resistance.

Authors:  Tongguo Shi; Chuanqiang Zhang; Suhua Xia
Journal:  Mol Cell Biochem       Date:  2022-02-10       Impact factor: 3.396

2.  Ovatodiolide Suppresses Oral Cancer Malignancy by Down-Regulating Exosomal Mir-21/STAT3/β-Catenin Cargo and Preventing Oncogenic Transformation of Normal Gingival Fibroblasts.

Authors:  Jia-Hong Chen; Alexander T H Wu; Oluwaseun Adebayo Bamodu; Vijesh Kumar Yadav; Tsu-Yi Chao; Yew-Min Tzeng; Debabrata Mukhopadhyay; Michael Hsiao; Jih-Chin Lee
Journal:  Cancers (Basel)       Date:  2019-12-24       Impact factor: 6.639

Review 3.  The Role of Noncoding RNAs in the Regulation of Anoikis and Anchorage-Independent Growth in Cancer.

Authors:  Han Yeoung Lee; Seung Wan Son; Sokviseth Moeng; Soo Young Choi; Jong Kook Park
Journal:  Int J Mol Sci       Date:  2021-01-10       Impact factor: 5.923

4.  Long non-coding RNA CASC2 upregulates PTEN to suppress pancreatic carcinoma cell metastasis by downregulating miR-21.

Authors:  Hui Zhang; Xielin Feng; Mingyi Zhang; Aixiang Liu; Lang Tian; Wentao Bo; Haiqing Wang; Yong Hu
Journal:  Cancer Cell Int       Date:  2019-01-16       Impact factor: 5.722

Review 5.  The Regulatory Role of Non-coding RNAs on Programmed Cell Death Four in Inflammation and Cancer.

Authors:  Mengxiang Zhao; Nisha Zhu; Fengyao Hao; Yuxian Song; Zhiyong Wang; Yanhong Ni; Liang Ding
Journal:  Front Oncol       Date:  2019-09-18       Impact factor: 6.244

6.  MicroRNAs as a Suitable Biomarker to Detect the Effects of Long-Term Exposures to Nanomaterials. Studies on TiO2NP and MWCNT.

Authors:  Sandra Ballesteros; Gerard Vales; Antonia Velázquez; Susana Pastor; Mohamed Alaraby; Ricard Marcos; Alba Hernández
Journal:  Nanomaterials (Basel)       Date:  2021-12-20       Impact factor: 5.076

Review 7.  Interrelationship between miRNA and splicing factors in pancreatic ductal adenocarcinoma.

Authors:  I Gede Putu Supadmanaba; Giulia Mantini; Ornella Randazzo; Mjriam Capula; Ittai B Muller; Stella Cascioferro; Patrizia Diana; Godefridus J Peters; Elisa Giovannetti
Journal:  Epigenetics       Date:  2021-05-30       Impact factor: 4.528

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.